The first time this happened, the instinct is to call a psychiatrist or quietly google 'early psychosis.' That spiral of terror is the worst part — not the symptom itself. What nobody tells women is that this particular strangeness has a precise biological explanation tied to hormones, and once you see the mechanism clearly, the feeling loses almost all of its power to frighten.
Learn more about Rose →Estrogen metabolizes in the brain into neuroactive steroids called allopregnanolone precursors, which act as potent positive modulators of GABA-A receptors — the brain's primary inhibitory, calming system. When estrogen levels drop sharply or fluctuate erratically in perimenopause, GABA-A receptor sensitivity becomes unstable, reducing the brain's ability to maintain its baseline state of integrated, grounded perception. Depersonalization and derealization are well-documented consequences of GABAergic dysregulation across multiple clinical contexts, including benzodiazepine withdrawal and anesthetic emergence, confirming the circuit-level link.
Estrogen upregulates serotonin synthesis, increases serotonin receptor density, and slows the reuptake of serotonin in key brain regions including the prefrontal cortex and anterior cingulate cortex — areas directly responsible for the integrated sense of being a continuous, embodied self. As estrogen withdraws in perimenopause, serotonin availability drops, and these regions lose part of their functional coherence, which is experienced subjectively as a blurring of the boundary between self and surroundings. SSRIs, which boost serotonergic transmission, are in fact a recognized clinical treatment for persistent depersonalization disorder, which is strong indirect evidence of this mechanism.
Each hot flash activates the hypothalamic-pituitary-adrenal (HPA) axis, producing a rapid spike in cortisol — the body's primary stress hormone. High cortisol acutely suppresses hippocampal function and alters activity in the default mode network, which is the brain system responsible for the sense of a coherent, located self, and disruptions to this network are one of the most reliable neural signatures of depersonalization. Women who experience frequent or nocturnal hot flashes may be cycling through mild dissociative states many times per day without recognizing the physiological trigger.
Chronic sleep fragmentation — the pattern produced by recurrent night sweats waking women in the early hours — is one of the most potent non-pharmacological inducers of derealization known in sleep science. The prefrontal cortex and thalamus, which together filter and integrate sensory input into a stable, coherent representation of reality, are acutely vulnerable to sleep loss and begin to malfunction after even two to three nights of disrupted sleep. This means a woman who attributes her 'unreal' feeling to something neurological or psychiatric may simply be profoundly sleep-deprived in a way that has a straightforward hormonal cause.
Perimenopausal anxiety frequently manifests as episodes of rapid, shallow breathing — sometimes barely noticed — which lower arterial carbon dioxide levels and cause cerebral vasoconstriction through a process called hypocapnia-induced vasoconstriction. The resulting reduction in cerebral blood flow produces classic derealization symptoms: tunneling vision, a sense of the world becoming flat or two-dimensional, and physical numbness, all of which are identical to the symptoms that send many women to emergency departments convinced they are having a stroke or breakdown. Rebreathing into cupped hands or practicing diaphragmatic breathing can abort these episodes within minutes, which is a useful confirmation that the mechanism is respiratory rather than structural.
The default mode network (DMN) — a connected set of brain regions including the medial prefrontal cortex, posterior cingulate, and angular gyrus — generates and maintains the continuous narrative of selfhood, and estrogen is a critical modulator of synaptic plasticity within it. Neuroimaging studies have shown measurable changes in DMN connectivity during the menopausal transition, correlating with reported cognitive and perceptual symptoms. When DMN coherence is reduced, the brain's ability to construct a stable, integrated sense of 'I am here, this is real' is genuinely compromised at a structural level — not metaphorically.
Women presenting with acute depersonalization or derealization in perimenopause are frequently routed toward psychiatric diagnoses — including panic disorder with psychotic features, dissociative identity disorder, or early schizophrenia — because the symptom pattern is unfamiliar to clinicians who have not been trained to connect it to hormonal transition. A 2022 review in the journal Maturitas noted that perimenopausal women are significantly more likely than younger women to receive inappropriate psychiatric diagnoses for symptoms that resolve partially or fully with hormone therapy. The misdiagnosis is not a failure of intelligence — it reflects a genuine gap in medical education about neuroendocrinology in midlife women.
Cortisol accelerates urinary magnesium excretion, and perimenopausal women under chronic stress or with frequent HPA activation from hot flashes can become functionally magnesium-depleted even with adequate dietary intake. Magnesium is an essential cofactor for GABA synthesis and a natural antagonist at NMDA glutamate receptors — and NMDA receptor hyperactivity is one of the confirmed neurochemical mechanisms underlying depersonalization, which is why ketamine (an NMDA blocker) can paradoxically both cause and sometimes relieve dissociative states. Repleting magnesium through diet or supplementation is therefore not a wellness trend in this context but a physiologically coherent intervention with a clear mechanistic rationale.
The terror of depersonalization and derealization is almost entirely driven by the catastrophic interpretation — 'I am losing my mind' — rather than by the sensory experience itself, and research on depersonalization disorder consistently shows that psychoeducation about the symptom's mechanism reduces its severity and frequency more reliably than many pharmacological interventions. When a woman understands that what she is experiencing is her GABAergic and serotonergic systems temporarily losing regulatory precision because of estrogen fluctuation, the emergency signal the brain generates about the experience is dramatically reduced. The symptom does not disappear overnight, but it stops being evidence of something irreversible — and that cognitive shift is genuinely therapeutic in a measurable neurological sense.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.